155 related articles for article (PubMed ID: 12750027)
21. Chiral pyrrolo[2,3-d]pyrimidine and pyrimido[4,5-b]indole derivatives: structure-activity relationships of potent, highly stereoselective A1-adenosine receptor antagonists.
Müller CE; Geis U; Grahner B; Lanzner W; Eger K
J Med Chem; 1996 Jun; 39(13):2482-91. PubMed ID: 8691445
[TBL] [Abstract][Full Text] [Related]
22. Pharmacology of adenosine A2A receptors and therapeutic applications.
Fredholm BB; Cunha RA; Svenningsson P
Curr Top Med Chem; 2003; 3(4):413-26. PubMed ID: 12570759
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and structure-activity relationships of deazaxanthines: analogs of potent A1- and A2-adenosine receptor antagonists.
Grahner B; Winiwarter S; Lanzner W; Müller CE
J Med Chem; 1994 May; 37(10):1526-34. PubMed ID: 8182711
[TBL] [Abstract][Full Text] [Related]
24. Xanthines as adenosine receptor antagonists.
Müller CE; Jacobson KA
Handb Exp Pharmacol; 2011; (200):151-99. PubMed ID: 20859796
[TBL] [Abstract][Full Text] [Related]
25. Structure-activity relationships at human and rat A2B adenosine receptors of xanthine derivatives substituted at the 1-, 3-, 7-, and 8-positions.
Kim SA; Marshall MA; Melman N; Kim HS; Müller CE; Linden J; Jacobson KA
J Med Chem; 2002 May; 45(11):2131-8. PubMed ID: 12014951
[TBL] [Abstract][Full Text] [Related]
26. Characterization of the potency, selectivity, and pharmacokinetic profile for six adenosine A2A receptor antagonists.
Yang M; Soohoo D; Soelaiman S; Kalla R; Zablocki J; Chu N; Leung K; Yao L; Diamond I; Belardinelli L; Shryock JC
Naunyn Schmiedebergs Arch Pharmacol; 2007 Apr; 375(2):133-44. PubMed ID: 17310264
[TBL] [Abstract][Full Text] [Related]
27. Novel multi-target directed ligands based on annelated xanthine scaffold with aromatic substituents acting on adenosine receptor and monoamine oxidase B. Synthesis, in vitro and in silico studies.
Załuski M; Schabikowski J; Schlenk M; Olejarz-Maciej A; Kubas B; Karcz T; Kuder K; Latacz G; Zygmunt M; Synak D; Hinz S; Müller CE; Kieć-Kononowicz K
Bioorg Med Chem; 2019 Apr; 27(7):1195-1210. PubMed ID: 30808606
[TBL] [Abstract][Full Text] [Related]
28. Xanthines with C8 chiral substituents as potent and selective adenosine A1 antagonists.
Peet NP; Lentz NL; Dudley MW; Ogden AM; McCarty DR; Racke MM
J Med Chem; 1993 Dec; 36(25):4015-20. PubMed ID: 8258823
[TBL] [Abstract][Full Text] [Related]
29. 7-Amino-2-phenylpyrazolo[4,3-d]pyrimidine derivatives: structural investigations at the 5-position to target human A₁ and A(2A) adenosine receptors. Molecular modeling and pharmacological studies.
Squarcialupi L; Colotta V; Catarzi D; Varano F; Betti M; Varani K; Vincenzi F; Borea PA; Porta N; Ciancetta A; Moro S
Eur J Med Chem; 2014 Sep; 84():614-27. PubMed ID: 25063944
[TBL] [Abstract][Full Text] [Related]
30. Synthesis of theophylline derivatives and study of their activity as antagonists at adenosine receptors.
Hierrezuelo J; Manuel López-Romero J; Rico R; Brea J; Isabel Loza M; Cai C; Algarra M
Bioorg Med Chem; 2010 Mar; 18(6):2081-2088. PubMed ID: 20202853
[TBL] [Abstract][Full Text] [Related]
31. An efficient route to xanthine based A(2A) adenosine receptor antagonists and functional derivatives.
Labeaume P; Dong M; Sitkovsky M; Jones EV; Thomas R; Sadler S; Kallmerten AE; Jones GB
Org Biomol Chem; 2010 Sep; 8(18):4155-7. PubMed ID: 20652178
[TBL] [Abstract][Full Text] [Related]
32. Synthesis, biological activity and molecular modelling studies of tricyclic alkylimidazo-, pyrimido- and diazepinopurinediones.
Drabczyńska A; Karcz T; Szymańska E; Köse M; Müller CE; Paskaleva M; Karolak-Wojciechowska J; Handzlik J; Yuzlenko O; Kieć-Kononowicz K
Purinergic Signal; 2013 Sep; 9(3):395-414. PubMed ID: 23543220
[TBL] [Abstract][Full Text] [Related]
33. Binding of [3H]MSX-2 (3-(3-hydroxypropyl)-7-methyl-8-(m-methoxystyryl)-1-propargylxanthine) to rat striatal membranes--a new, selective antagonist radioligand for A(2A) adenosine receptors.
Müller CE; Maurinsh J; Sauer R
Eur J Pharm Sci; 2000; 10(4):259-65. PubMed ID: 10838015
[TBL] [Abstract][Full Text] [Related]
34. Improving potency, selectivity, and water solubility of adenosine A1 receptor antagonists: xanthines modified at position 3 and related pyrimido[1,2,3-cd]purinediones.
Weyler S; Fülle F; Diekmann M; Schumacher B; Hinz S; Klotz KN; Müller CE
ChemMedChem; 2006 Aug; 1(8):891-902. PubMed ID: 16902942
[TBL] [Abstract][Full Text] [Related]
35. Structure-activity relationships in a series of 8-substituted xanthines as bronchodilator and A1-adenosine receptor antagonists.
Corsano S; Strappaghetti G; Scapicchi R; Lucacchini A; Senatore G
Arch Pharm (Weinheim); 1995 Sep; 328(9):654-8. PubMed ID: 7487422
[TBL] [Abstract][Full Text] [Related]
36. 1,3-dialkyl-8-N-substituted benzyloxycarbonylamino-9-deazaxanthines as potent adenosine receptor ligands: Design, synthesis, structure-affinity and structure-selectivity relationships.
Fernández F; Caamaño O; Isabel Nieto M; López C; García-Mera X; Stefanachi A; Nicolotti O; Isabel Loza M; Brea J; Esteve C; Segarra V; Vidal B; Carotti A
Bioorg Med Chem; 2009 May; 17(10):3618-29. PubMed ID: 19398343
[TBL] [Abstract][Full Text] [Related]
37. Synthesis, biological evaluation and molecular modelling studies of 1,3,7,8-tetrasubstituted xanthines as potent and selective A
Rohilla S; Bansal R; Kachler S; Klotz KN
Bioorg Chem; 2019 Jun; 87():601-612. PubMed ID: 30933785
[TBL] [Abstract][Full Text] [Related]
38. Novel 1,3-disubstituted 8-(1-benzyl-1H-pyrazol-4-yl) xanthines: high affinity and selective A2B adenosine receptor antagonists.
Kalla RV; Elzein E; Perry T; Li X; Palle V; Varkhedkar V; Gimbel A; Maa T; Zeng D; Zablocki J
J Med Chem; 2006 Jun; 49(12):3682-92. PubMed ID: 16759111
[TBL] [Abstract][Full Text] [Related]
39. Discovery of 1,3-diethyl-7-methyl-8-(phenoxymethyl)-xanthine derivatives as novel adenosine A
Harmse R; van der Walt MM; Petzer JP; Terre'Blanche G
Bioorg Med Chem Lett; 2016 Dec; 26(24):5951-5955. PubMed ID: 27836398
[TBL] [Abstract][Full Text] [Related]
40. Aza-analogs of 8-styrylxanthines as A2A-adenosine receptor antagonists.
Müller CE; Sauer R; Geis U; Frobenius W; Talik P; Pawlowski M
Arch Pharm (Weinheim); 1997 Jun; 330(6):181-9. PubMed ID: 9264243
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
